Martine Alhenc-Gelas Selected Research

Estrogens (Estrogen)

11/2010	Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen.
11/2006	[Coagulation factor mutations and thrombosis].
11/2005	Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
9/2003	Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martine Alhenc-Gelas Research Topics

Disease

11	Venous Thromboembolism 09/2020 - 08/2002
11	Venous Thrombosis (Deep-Vein Thrombosis) 09/2020 - 04/2003
7	Thrombocytopenia (Thrombopenia) 10/2021 - 09/2006
6	Thrombosis (Thrombus) 12/2016 - 08/2003
4	Activated Protein C Resistance (APC Resistance) 02/2017 - 09/2003
4	Protein S Deficiency (Deficiency, Protein S) 01/2017 - 04/2003
3	Hemorrhage 12/2016 - 04/2002
2	Wounds and Injuries (Trauma) 01/2021 - 07/2012
2	Protein C Deficiency 01/2018 - 01/2004
2	Inflammation (Inflammations) 01/2018 - 04/2016
2	Coronary Disease (Coronary Heart Disease) 06/2011 - 05/2006
2	Fever (Fevers) 01/2005 - 08/2003
1	Congenital Disorders of Glycosylation 01/2018
1	Multiple Abnormalities 01/2018
1	Hypoprothrombinemias (Prothrombin Deficiency) 04/2015
1	Arthritis (Polyarthritis) 04/2015
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2014
1	Thromboembolism 03/2013
1	Pulmonary Embolism 07/2012
1	Ischemic Stroke 06/2011
1	Hypertension (High Blood Pressure) 05/2006
1	Necrosis 01/2004
1	Protein Deficiency 08/2003
1	Factor VII Deficiency (Hypoproconvertinemia) 04/2002
1	Disease Susceptibility (Diathesis) 04/2002
1	Carotid Artery Diseases 02/2002
1	Atherosclerosis 02/2002

Drug/Important Bio-Agent (IBA)

9	AntithrombinsIBA 01/2018 - 08/2003
7	Heparin (Liquaemin)FDA LinkGeneric 10/2021 - 09/2006
5	Protein CIBA 09/2020 - 09/2003
5	factor V LeidenIBA 01/2014 - 08/2002
4	Estrogens (Estrogen)FDA Link 11/2010 - 09/2003
3	Hormones (Hormone)IBA 08/2011 - 11/2005
2	Oral ContraceptivesIBA 09/2020 - 03/2011
2	AnticoagulantsIBA 09/2020 - 01/2018
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2018 - 11/2006
2	RivaroxabanIBA 01/2018 - 07/2014
2	Prothrombin (Factor II)IBA 02/2017 - 08/2002
2	Thrombin FDA Link 08/2011 - 06/2011
2	Progestins (Progestagens)IBA 03/2011 - 11/2010
2	lepirudin (Refludan)FDA Link 03/2011 - 09/2006
2	SerpinsIBA 06/2006 - 08/2003
2	AntigensIBA 05/2006 - 01/2005
1	AntibodiesIBA 10/2021
1	Serotonin (5 Hydroxytryptamine)IBA 10/2021
1	RNA Splice SitesIBA 09/2020
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	Polysaccharides (Glycans)IBA 01/2018
1	CarbohydratesIBA 01/2018
1	Protein SIBA 02/2017
1	Contraceptive Agents (Contraceptives)IBA 02/2017
1	danaparoid (Orgaran)FDA Link 12/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2016
1	Rosuvastatin Calcium (Crestor)FDA Link 04/2016
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 04/2015
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 07/2012
1	FibrinIBA 08/2011
1	Biomarkers (Surrogate Marker)IBA 08/2011
1	Biological ProductsIBA 03/2011
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 03/2011
1	PlasminogenIBA 03/2011
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2011
1	fibrin fragment D (D-dimer)IBA 03/2011
1	Progesterone FDA LinkGeneric 11/2010
1	NorpregnanesIBA 11/2010
1	antithrombin Cambridge IIIBA 10/2007
1	Fibrinogen (Factor I)FDA Link 05/2006
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2006
1	Triglycerides (Triacylglycerol)IBA 05/2006
1	CholesterolIBA 05/2006
1	Plasminogen InactivatorsIBA 05/2006
1	Glucose (Dextrose)FDA LinkGeneric 05/2006
1	Plasminogen Activator Inhibitor 1IBA 05/2006
1	Nadroparin (Nadroparin Calcium)IBA 01/2004
1	coumarinIBA 01/2004
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 08/2002
1	Factor VII (Proconvertin)IBA 04/2002
1	ThrombomodulinIBA 02/2002

Therapy/Procedure

6	Therapeutics 12/2016 - 01/2004
2	Estrogen Replacement Therapy 09/2003 - 02/2002
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2021
1	Art Therapy 04/2016
1	Contraception (Birth Control) 11/2006
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 02/2002